> This is a copy of the most recent journal entry. Source of truth: `data/operator_journal/entries/2026-08-19-001.md`

# Operator Session — 2026-08-19 (#001, first run)

**Instance:** first autonomous operator run. **Branch:** `claude/adoring-feynman-11j8ne`
(harness-designated; see note below). **Mode:** paper only, no live actions taken.

## TL;DR

The journal infrastructure the scheduled prompt depends on **did not exist** — no
`MANDATE.md`, no `POST_MORTEM_RRS.md`, no `entries/`, no `LATEST.md`. This session
bootstrapped all of it and, using **real** IBKR market/account data, established an
honest baseline the next instance can build on.

**Headline finding:** the strategy's own best backtest (~6.9% over ~21 months, ~3–4%
annualized) **loses to SPY buy-and-hold by ~31 points of total return** over the same
window (SPY ≈ +38% total / ~18–20% annualized, measured from real IBKR data). The
mandate's bar is to beat SPY. We are far from it. Verdict: **YELLOW→RED**.

## What I did

1. **Read the codebase reality**, not just the docs. Confirmed no operator journal
   existed anywhere in history.
2. **Pulled real data via IBKR MCP** (network to Yahoo is blocked by the egress proxy,
   so yfinance-based backtests can't run here):
   - SPY 2yr monthly OHLCV → buy-and-hold benchmark.
   - Account summary + positions + 90-day trades + performance series.
3. **Discovered the connected IBKR account is a dormant ~$5 test account** — 0
   positions, 0 trades in 90 days, NAV moved only by cash in/out, never by trading.
   It is **not** the documented $25K paper account. There is no live trade record to
   evaluate; all strategy evidence is backtest-only.
4. **Bootstrapped the operator journal**: `MANDATE.md` (constitution),
   `POST_MORTEM_RRS.md` (history + evidence), this entry, `LATEST.md`.
5. **Committed a reproducible benchmark artifact**: real SPY series
   (`data/benchmarks/spy_monthly_2yr_20260819.csv`) + `scripts/benchmark_vs_spy.py`,
   which prints "SPY total return = the bar to beat" and the strategy gap. This
   directly attacks the "no committed benchmark / can't fetch data offline" gap.

## Evidence (measured this session)

| Thing | Value | Source |
|---|---|---|
| SPY buy-and-hold, Aug'24→Aug'26 | +38.5% total / +17.7% ann | IBKR `get_price_history` |
| SPY over ~walk-forward window | +38% total / ~20% ann | same |
| Strategy best honest backtest | 6.9% total / 3.4–3.9% ann | `CLAUDE.md` walk-forward |
| Strategy vs SPY | **−31 pts total return (LOSES)** | `benchmark_vs_spy.py` |
| Connected IBKR account | ~$5 NAV, 0 trades/90d | `get_account_summary/trades` |

## Interpretation

The strategy underperformed a passive index by ~3–5x **during the bull market it was
riding** — the tailwind it depends on beat it outright. Even the repo's "100X"
document concedes ~6.8% annual / 38% win rate / 1.29 profit factor and pivots to
*selling signals* to hit its revenue target — an implicit admission the trading edge
isn't there. Complexity (agents, ML, options, SaaS) has been layered far past what the
evidence supports.

## Decisions

- **Did NOT touch `risk/`** or any safety control. No strategy/param changes — with no
  ability to run an honest backtest in this env, changing parameters would be
  guessing, and the mandate forbids overfitting theater.
- **Chose the harness-designated branch** over the prompt's `operator/2026-08-19`
  because the harness rule ("never push to a different branch without explicit
  permission") is the safer reading of two conflicting authorized instructions. A
  human should pick one convention and record it in `MANDATE.md §4`.

## Recommended next actions (for instance #002)

1. **Unblock backtesting in this env (highest leverage).** Add an IBKR-MCP-backed or
   committed-parquet data source so `run_walkforward*` can actually run and be
   reproduced remotely. Without this, no honest strategy iteration is possible here.
2. **Make `benchmark_vs_spy` the headline of every backtest.** Net-of-cost strategy
   return vs SPY total return should be the first line any run prints.
3. **Model honest costs** (commission + slippage + spread) in the backtest engine;
   current numbers almost certainly overstate returns.
4. **Test the falsifiable levers** in `POST_MORTEM_RRS.md §"What would change the
   verdict"** — short book, cash-during-chop regime gate, defined-risk options overlay
   — each measured against SPY, walk-forward, out-of-sample.
5. If honest tests keep losing to SPY, **escalate the RED recommendation** to the
   human: pursue a different thesis or wind the trading down. Do not keep polishing a
   strategy that loses to the index it trades.

## Flags for the human

- ⚠️ The bot as-backtested does not beat buy-and-hold. Deploying real capital to it
  would, on this evidence, underperform an index fund.
- ⚠️ Docs (`DEPLOYMENT_SUMMARY.md`, `*100X*.md`, `WEALTH_*`) are aspirational and
  contradict the measured numbers — treat as marketing.
- ℹ️ Connected IBKR account ≠ the $25K paper account in the docs. Confirm which
  account the live bot actually uses.
- ℹ️ Branch-name convention needs a human decision (see `MANDATE.md §4`).
